Abstract
Obsessive-compulsive disorder (OCD) has attracted the attention of many investigators from time immemorial because of the rarity of the disease, the distinctive clinical picture, and the ego-alien nature of the symptoms. Over time, many methods of treatment have been tried, unfortunately, with little success. Thus, pessimism has been generally expressed by many workers regarding the outcome of therapeutic intervention (Kolb, 1968; Lewis, A., 1935; Pollitt, 1957). However, with the progress achieved over the past 20 years in the psychological and somatic treatments of this disorder, there is reason for optimism. Hopefully, the new directions will also provide new insights in the understanding of this crippling disorder. Basic to treatment and evaluation of efficacy are the problems of diagnosis, assessment, and the rationale for treatment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Akimoto, H., Nakakuki, M., & Machiyama, Y. Clinical experiences with MAO inhibitors (a comparison with Tofranil). Diseases of the Nervous System, 1960, 21, 645–647.
Altschuler, M. Massive doses of trifluoperazine in the treatment of compulsive rituals. American Journal of Psychiatry, 1962, 119, 367–368.
Alzheimer, O. Zur Pharmacotherapie depressiver erkrankungen. Medizinische Welt, 1960, 37, 1918–1926.
Amat Aguirre, E. Tratamiento de las depresiones atfpicas. Revue Informacion Medicale-Thera pie, 1966, 41, 387–392.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders ( 3rd ed. ). Washington, DC: Author, 1980.
Amin, M. M., Ban, T. A., Pecknold, J. C., & Klingner, A. Clomipramine (Anafranil) and behavior therapy in obsessive-compulsive and phobic disorders. Journal of International Medical Research, 1977, 5, (Suppl. 5), 33–37.
Ananth, J. Pathophysiology of tardive dyskinesia. Neu ropsychobiology, 1982, 8, 210–212.
Van Den Steen, N. Systematic studies in the treatment of obsessive-compulsive neurosis with tricyclic antidepressants. Current Therapeutic Research, 1977, 21, 495–501.
Ananth, J., Solyom, L., Solyom, C., & Sookman, D. Doxepin in the treatment of obsessive compulsive neurosis. Psychosomatics, 1975, 16, 185–187.
Ananth, J., Solyom, L., Bryntwick, S., & Krishnappa, U. Clomipramine therapy for obsessive compulsive neurosis. American Journal of Psychiatry, 1979, 135, 700–701.
Ananth, J., Pecknold, J., Van Den Steen, N., & Engelsmann, F. Double-blind comparative study of clomipramine and amitriptyline in obsessive neurosis. Progress in Neuro-Psychopharmacology, 1981, 5, 257–262.
Anden, N. G. Oral L-dopa treatment of Parkinsonism. Acta Medica Scandinavica, 1970, 187, 247–255.
Annesley, P. T. Nardil response in a chronic obsessive compulsive. British Journal of Psychiatry, 1969, 115, 748.
Baker, E. F. W., Young, M. P., & Gould, D. M. A new look at bimedial prefrontal leukotomy. Canadian Medical Association Journal, 1970, 102, 37–41.
Barbeau, A. Long-term side effects of levodopa. Lancet, 1971, 1, 395.
Bauer, G., & Novak, H. Doxepine ein neuves Antidepressivum; Wirkungvergleich mit Amitriptylin. Arzneimittel-Forschung, 1969, 19, 1642–1646
Bernstein, I., Callahan, W. A., & Jaranson, J. M. Lobotomy in private practice. Archives of General Psychiatry, 1975, 32, 1041–1047.
Bethume, H. C. A new compound in the treatment of anxiety states: Report on the use of diazepam. New Zealand Medical Journal, 1964, 63, 153–156.
Black, A. The natural history of obsessional neurosis. In H. H. Beech, H. H. (Ed.), Obsessive states. London: Methuen, 1974.
Bonis, A., Covello, L., & Lemperiere, T. Etude critique des indications d’ interventions psychochirurgicales. Encephale, 1968, 57, 439–473, 525–563.
Boucquey, J., & Boucquey, J. P. Traitement ambulatoire à l’imipramine de 50 cas de psychoneurosis. Revue Médicale de Louvain, 1961, 5, 126–142.
Brickner, R. M., Rosen, A. A., & Munro, R. Physiological aspects of the obsessive state. Psychosomatic Medicine, 1940, 2, 369–383.
Bridges, P. K., Goktepe, E. O., Maratos, J., Browne, A., & Young, L. A comparative review of patients with obsessional neurosis and with depression treated by psychosurgery. British Journal of Psychiatry, 1973, 123, 663–674.
Brietner, C. Drug therapy in obsessional states and other psychiatric problems. Diseases of the Nervous System (Suppl.) 1960, 21, 31–35.
Brown, F. W. Heredity in psychoneuroses. Proceedings of the Royal Society of Medicine, 1942, 35, 785–790.
Burckhardt, G. Uber Rindenexcisionen, als Beitrag zur operativen Therapie der Psychosen. Allgemeine Zeitschrift Peur Psychiatrie, 1890, 74, 463.
Burrell, R. H., Culpan, R. H., Newton, K. J. Use of bromazepam in obsessional, phobic and related states. Current Medical Research Opinion, 1974, 2, 430–436.
Campbell, B., Gomez, L., Ananth, J. V., Bronheim, L. A., Klingner, A., & Ban, T. A. An uncontrolled clinical trial with clomipramine in the treatment of depressed patients. Current Therapeutic Research, 1973, 15, 223–231.
Cartes Egea, F. Observaciones sobre el tratamiento ambulatorio de los estados depresivos con G 22355 (Tofranil). Medicina Clinica (Barcelona), 1961, 36, 448–452.
Carman, J. S. Hyperdopaminergic states: A continuum. Lancet, 1972, 2, 1249.
Cassano, G. G., Castrogiovanni, P., & Mauri, M. A multicenter controlled trial in phobic-obsessive psychoneurosis. The effect of chlorimipramine and its combinations with haloperidol and diazepam. Progress in Neuropsychopharmacology, 1981, 5, 129–138.
Chapel, J. L. Gilles de la Tourette’s disease—The past and the present. Canadian Psychiatric Association Journal, 1966, 11, 324–329.
Cooper, J. E. The Leyton Obsessive Inventory. Psychological Medicine, 1970, 1, 48–64.
Lopez-Ibor Alino, J. J. La monochlorimiprame en enfornes psychiatrices resistantes en otros tratamientos. Acta Luso Espanol Neurologi Psychiatri, 1967, 26, 119–147.
Crawford, J. F. Cerebral autonomic imbalance. Lancet, 1973, 2, 772–773.
Creese, I., Bivet, D. R., & Snyder, S. H. Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity. Science, 1977, 197, 596–598.
Cruz, M. de la, & Sarro-Martin, A. Experiencias con un nuevo antidepressivo derivado del iminodibencilo. Medicina Clinica (Barcelona), 1959, 33, 122–125.
Daily, P. Chemotherapy of psychiatric disorders. London: Logos Press, 1967.
Dubois, J. C., & Rancurel, G. Vol et melancolie: A propos de cinq observations. Annales Médico-Psychologiques (Paris), 1967, 125, 572–579.
Earle, B. V., & Earle, A. M. Imipramine (Tofranil) in mental health clinic and private practice. Canadian Medical Association Journal, 1960, 83, 804–806.
Ellinwood, E. H., Jr. Amphetamine psychosis. I. Description of the individuals and the process. Journal of Nervous and Mental Disease, 1967, 144, 273–283.
Ellinwood, E. H., Jr., & Escalante, O. Chronic amphetamine effect on the olfactory forebrain. Biological Psychiatry, 1970, 2, 189–203.
Escobar, J., Teeter, R. R., Tuason, V. B., & Schiele, B. C. Intravenous chlorimipramine and depressive subtypes. Diseases of the Nervous System, 1976, 37, 325–328.
Eysenck, H. The manual of Maudsley Personality Inventory. London: University of London Press, 1959.
Freed, A., Kerr, T. A., & Roth, M. The treatment of obsessional neurosis. British Journal of Psychiatry, 1972, 120, 590–591.
Freeman, W., & Watts, J. W. Psychosurgery: An evaluation of 200 cases over seven years. Journal of Mental Science, 1944, 90, 379–532.
Frossman, H., & Walinder, J. Lithium treatment on atypical indication. Acta Psychiatrica Scandinavica, 1969 (Suppl. 207 ), 34–40.
Garmany, G., May, A. R., & Folkson, A. The use and action of chlorpromazine in psychoneuroses. British Medical Journal, 1954, 3, 439–441.
Gattuso, S., & Coaciuri, V. L’imipramine nella terapia della nevrosi assessiva. Acta Neurologica (Napoli) 1964, 19, 424–431.
Geister, A., & Schou, M. Lithium for obsessive neurosis. Nordisk Psykiatrisk Tidsskrift, 1969, 23, 493–495.
Geissmann, P., & Kammerer, T. L’imipramine dans la nevrose obsessionnelle. Etude de 30 cas. Encephale, 1964, 53, 369–382.
Gittelson, N. L. The effect of obsessions in depressive psychosis. British of Psychiatry, 1966, 112, 253–259.
Gittelson, N. L. The phenomenology of obsessions in depressive psychosis. British Journal of Psychiatry, 1996, 112, 261–264.
Gittelson, N. L. The fate obsessions in depressive psychosis. British Journal of Psychiatry, 1966, 112, 705–708.
Gittelson, N. L. Depressive psychosis in obsessional neurotics. British Journal of Psychiatry, 1966, 112, 883–887.
Goodwin, D. W., Guze, S. B., & Robins, E. Follow up studies in obsessional neurosis. Archives of General Psychiatry, 1969, 20, 182–187.
Grimshaw, L. The outcome of obsessional disorder: A follow up study of 100 cases. British Journal of Psychiatry, 1965, 111, 1051–1056.
Guyotat, J., Marin, A., Dubor, P., & Bonhomme, R. L’imipramine en dehors des états dépressifs. Journal Médicale Lyon, 1960, 41, 367–375.
Hohne, H. H., & Walsh, K. W. Surgical modification of personality: Mental health research project. Melbourne, Australia: Victorian Mental Health Authority, 1970.
Holden, J. M. C., Itil, T. M., & Hofstatter, L. Prefrontal lobotomy: Stepping stone or pitfall ? American Journal of Psychiatry, 1970, 127, 591–598.
Hussain, M. Z., & Ahad, A. Treatment of obsessive compulsive neurosis. Canadian Medical Association Journal, 1970, 103, 648–650.
Insel, T. R., & Murphy, D. L. The pharmacological treatment of obsessive-compulsive disorder: A review. Journal of Clinical Psychopharmacology, 1981, 1, 304–311.
Isberg, R. S. A comparison of phenelzine and imipramine in an obsessivecompulsive patient. American Journal of Psychiatry, 1981, 138, 1250–1251.
Jain, V. K., Swinson, R. P., & Thomas, J. G. Phenelzine in obsessional neurosis. British Journal of Psychiatry, 1970, 117, 237–238.
Janowski, D. S., Davis, J. M., El Yousef, M. K., & Sekerke, H. J. A cholinergicadrenergic hypothesis of mania and depression. Lancet, 1972, 2, 632–635.
Jenike, M. A. Rapid response of severe obsessive compulsive disorder to tranylcypromine. American Journal of Psychiatry, 1981, 138, 1249–1251.
Jimenz Garcia, P. Experiencia clinica con clomipramina en enfermos psychiâtricos. Libro de Becas Cursos, 1967, 58, 179–201.
Kalinowsky, L. B., & Hippius, H. Pharmacological, convulsive, and other somatic treatments in psychiatry. New York: Grune & Stratton, 1969.
Kalinowsky, L. G., & Hoch, P. H. Somatic treatments in psychiatry. New York: Grune & Stratton, 1961.
Kanner, L. Clinical psychiatry ( 3rd ed. ). Springfield, IL: Charles C Thomas, 1957.
Karabanow, O. Double-blind controlled study in phobias and obsessions complicated by depression. International Journal of Medical Research, 1977, 5, (Suppl. 5), 42–48.
Kelly, D., Walter, C. J. S., & Mitchell-Heggs, N. Modified leucotomy assessed clinically, physiologically and psychologically at six weeks and eighteen months. British Journal of Psychiatry, 1972, 120, 19–29.
Kelly, D. Therapeutic outcome in limbic leucotomy in psychiatric patients. Psychiatry, Neurology, Neurosurgery (Amsterdam), 1976, 76, 353–363.
Kendell, R. E., & Discipio, W. J. Obsessive symptoms and obsessional personality traits in patients with depressive illnesses. Psychological Medicine, 1970, 1, 65–72.
Klawan, H. L. The pharmacology of tardive dyskinesia. American Journal of Psychiatry, 1973, 130, 82–86.
Knight, G. Bifrontal stereotractotomy. British Journal of Psychiatry, 1969, 115, 257–266.
Kolb, L. C. Noyse’s modern clinical psychiatry. Philadelphia: W. B. Saunders, 1968.
Kramer, M. Delirium as a complication of imipramine therapy in the aged. American Journal of Psychiatry, 1963, 120, 502–503.
Kringlen, E. Natural history of obsessional neurosis. Seminars in Psychiatry, 1970, 2, 403–419.
Laboucarie, J., Rascol, A., Jorda, P., Guraud, R., & Leinadier, H. New prospects in the treatment of melancholic states. Therapeutic study of a major antidepressant, chlorimipramine. Revue Médicale de Toulouse, 1967, 3, 863–872.
Lewin, W. Selective leucotomy: A review. In L. Laininen & K. E. Livingston (Eds.), Surgical approaches in psychiatry. England: Medical and Technical Publishing Co., Ltd., 1973.
Lewis, A. Problems of obsessional illness. Proceedings of the Royal Society of Medicine, 1935, 29, 325–336.
Linford-Rees, W. The value and limitations of psychosurgery in the treatment of psychiatric illness. Psychiatry, Neurology, Neurosurgery (Amsterdam), 1973, 76, 323–334.
Lo, W. H. A follow-up study of obsessional neurotics in Hong Kong Chinese. British Journal of Psychiatry, 1997, 113, 823–832.
Lopez-Ibor, Alino, J. J. Intravenous perfusion of monochlorimipramine. Techniques and results. In Proceedings of the International College of CINP, Teragone, April, 1968 (International Congress Series, 180, 519 ). Netherlands. Excerpta Medica, 1969.
Marks, I. M., Birley, J. L. T., & Gelder, M. G. Modified leucotomy in severe agoraphobia: A controlled serial enquiry. British Journal of Psychiatry, 1966, 112, 757–769.
Marks, I. M., Stern, R. S., Mawson, D., Cobb, J., & McDonald, R. Clomipramine and exposure for obsessive-compulsive rituals. British Journal of Psychiatry, 1980, 136, 1–25.
Marshall, W. K. Treatment of obsessional illness and phobic anxiety state with clomipramine. British Journal of Psychiatry, 1971, 119, 467–468.
Marshall, W. K. & Micev, V. Clomipramine in the treatment of obsessional illness and phobic anxiety states. Journal of International Medical Research, 1973, 1, 403–412.
Matigama, Y., Kuroiwa, S., & Naruse, H. Some clinical experience with a new iminodibenzyl derivative G.22344 (Tofranil) (Japan). Bulletin of the SeishinIgaku Institute [Clinical Psychiatry], 1959, 1, 581–585.
Meyer, G., McElhaney, M., Martin, W., & McGraw, C. P. Stereotactic cingulotomy with results of acute stimulation and serial psychological testing. In L. Laininen & K. E. Livingston (Eds.), Surgical Approaches in Psychiatry. Baltimore: Baltimore University Press, 1973.
Meyer-Gross, W., Slater, E., & Roth, M. Clinical Psychiatry. London: Bailliere, Tindal & Cassell, 1969.
Michaux, L., Duche, D., & Perpinoitis. Etude pharmocodynamique, clinique et therapeutique du G22344 en pedo-psychiatrie. Proceedings of the 3rd World Congress of Psychiatry, Montreal, 1961, 2, 927–929 (McGill, Montreal, 1961 ).
Miller, H. Psychosurgery & Dr. Breggin. New Scientist, 1972, 55, 188–190.
Moniz, E. Tentative opératoires dans le traitement de certaine psychoses. Paris: Masson, 1936.
Naviau, J., Ruyffelaere, J., & Lehembre, C. A propos de deux cas de nevrose obsessionnelle. Annales Médico-Psychologiques (Paris) 1966, 124, 254–258.
Nauta, W. J. H. Some efferent connections of the prefrontal cortex in the monkey. In J. W. Warren & K. Akert (Eds.), Frontal granular cortex and behavior. New York: McGraw-Hill, 1964.
O’Reagan, J. B. Treatment of obsessive compulsive neurosis with haloperidol. Canadian Medical Association Journal, 1970, 103, 167–168.
Orvin, G. H. The treatment of the phobic obsessive compulsive patient with oxazepam, an improved benzodiazepine compound. Psychosomatics, 1967, 8, 278–280.
Owen, F., Crow, T. J., Foulter, M., Cross, A. J., Longden, A., & Riley, G. J. Increased dopamine-receptor sensitivity in schizophrenia. Lancet, 1978, 2, 223–226.
Philpott, R. Recent advances in the behavioral measurement of obsessional difficulties common to these and other measures. Scottish Medical Journal, 1975, 20, 33–40.
Pippard, J. Rostral leucotomy: A report on 240 cases personally followed up after 11/2 to 5 years. Journal of Mental Science, 1955, 101, 756–773.
Pollitt, J. Natural history of obsessional states. British Medical Journal, 1957, 1, 194–198.
Post, F., Rees, W. L., & Schurr, P. H. An evaluation of bimedial leucotomy. British Journal of Psychiatry, 1968, 114, 1223–1246.
Prange, A. J., Sisk, J. L., Wilson, I. C., Morris, C. E., Hall, C. D., Carman, J. S. Proceedings of N.I.M.H. Serotonin Conference, Palo Alto, California. Washington: U.S. Government Printing Office, 1972.
Rabavilas, A. D., Boulougouris, J. C., Perissaki, C., & Stefanis, C. The effect of peripheral beta-blockade on psychophysiologic responses in obsessional neurotics. Comprehensive Psychiatry, 1979, 20, 378–383.
Rachman, S., Cobb, J., Grey, S., McDonald, B., Mawson, D., Sartory, G., & Stern, R. The behavioral treatment of obsessional-compulsive disorders with or without clomipramine. Behavioral Research & Therapy, 1979, 17, 467–478.
Rachman, S. J., & Hodgson, R. J. Obsessions and compulsions. Englewood Cliffs, NJ: Prentice-Hall, 1980.
Rao, A. V. A controlled trial with “valium” in obsessive compulsive state. Journal of the Indian Medical Association, 1964, 42, 564–567.
Rapoport, J., Elkins, R., & Müelsen, E. A clinical controlled trial of chlorimipramine in adolescents with obsessive compulsive disorder. Psychopharmacology Bulletin, 1980, 16, 61–63.
Renynghe de Voxrie, G. V. L’Anafranil dans l’obsession. Acta Neurologica Belgica, 1968, 68, 787–792.
Robins, A. H. Depression in patients with Parkinsonism. British Journal of Psychiatry, 1976, 128, 141–145.
Rosenberg, C. M. Complications of obsessional neurosis. British Journal of Psychiatry, 1968, 114, 477–478.
Rylander, G. Clinical and medico criminological aspects of addictions to central stimulating drugs. In E. Sjoquist & E. Tottie (Eds.) Abuse of central stimulants. New York: Raven Press, 1969.
Sakai, T. Clinicogenetic study on obsessive compulsive neurosis. Bulletin of Osaka Medical School, 1968, (Suppl. 12 ), 323–331.
Sargant, W. & Slater, E. Discussion on the treatment of obsessional neuroses. Proceedings of the Royal Society of Medicine, 1950, 43, 1007–1010.
Sargent, W. The present indications for leucotomy. Lancet, 1992, 1, 1197–1200.
Schilder, P. The organic background of obsessions and compulsions. American Journal of Psychiatry, 1938, 94, 1397–1416.
Schildkrout, J. J., & Kety, S. S. Biogenic amines and emotion. Science, 1967, 156, 21–30.
Scoville, W. B. Late results of orbital undercutting. Report of 76 patients undergoing quantitative selective lobotomies. American Journal of Psychiatry, 1960, 117, 525–532.
Shader, R. I. Antianxiety agents: A clinical perspective. In A. DiMascio & R. Shader (Eds.), Clinical handbook of psychopharmacology. New York: Science Press, 1970. 71–77.
Shapiro, A. K., Shapiro, G., & Wayne, H. Treatment of Tourette’s syndrome. Archives of General Psychiatry, 1973, 28, 92–97.
Shobe, F. O., & Gildea, M. C. L. Long-term follow-up of selected lobotomized private patients. Journal of American Medical Association, 1968, 206, 327–332.
Singer, K. Gilles de la Tourette’s disease. American Journal of Psychiatry, 1963, 20, 80–81.
Slater, E., & Roth, M. Clinical psychiatry (3rd ed.). Baltimore, MD: William & Wilkins, 1969.
Snyder, S. Amitriptyline treatment of obsessive compulsive neurosis. Journal of Clinical Psychiatry, 1980, 41, 286–289.
Solyom, L., & Sookman, D. A comparison of clomipramine hydrochloride (Anafranil) and behavioral therapy in the treatment of obsessive neurosis. Journal of International Medical Research, 1977, 5 (Suppl. 5), 49–61.
Stern, T. A., & Jenike, M. A. Treatment of obsessive compulsive disorder with lithium carbonate. Psychosomatics, 1983, 24, 671–673.
Strauss, H. Office treatment of depressive states with a new drug (imipramine). New York State Journal of Medicine, 1959, 59, 2906–2910.
Strom-Olsen, R., & Carlisle, S. Bifrontal stereotractotomy: A follow up study of its effects on 210 patients. British Journal of Psychiatry, 1971, 118, 141–154.
Sykes, M. K., & Tredgold, R. F. Restricted orbital undercutting: A study of its effects on 350 patients over the ten years, 1951–1960. British Journal of Psychiatry, 1964, 110, 609–640.
Tan, E., Marks, I. M., & Marset, P. Bimedial leucotomy in obsessive compulsive neurosis: A controlled serial enquiry. British Journal of Psychiatry, 1971, 118, 155–164.
Taylor, K. M., & Snyder, S. H. Amphetamine differentiation of D- and L-isomers of animal behavior involving central norepinephrine or dopamine. Science, 1970, 168, 1487–1489.
Templer, D. I. The obsessional neurosis: A review of research findings. Comprehensive Psychiatry, 1972, 13, 375–383.
Thoren, P., Asberg, M., Cronholm, B., Jorenstedt, L., & Traskman, L. Clomipramine treatment of obsessive-compulsive disorder: A controlled clinical trial. Archives of General Psychiatry, 1980, 37, 1281–1289.
Tooth, G. C., & Newton, M. P. Leucotomy in England and Wales. London: Her Majesty’s Stationery Office, 1961.
Trethowan, W. F., & Scott, P. A. L. Chlorpromazine in obsessive-compulsive neurosis and allied disorders. Lancet, 1955, 1, 781–785.
Tucker, W. I. Indications for modified leucotomy. Lahey Clinic Foundation Bulletin, 1966, 15, 131–139.
Turner, S. M., Hersen, M., Bellack, A. S., Andrasik, F., & Capparell, H. V. Behavioral and pharmacological treatment of obsessive-compulsive disorders. Journal of Nervous and Mental Disease, 1980, 168, 651–657.
Vanggard, T. The concept of neurosis. Acta Psychiatrica Scandinavica, 1959, 16, 117–136.
Van Hoesen, G. W., Pandya, D. N., & Butters, N. Cortical afferents to the entorhinal cortex of the rhesus monkey. Science, 1972, 175, 1471–1473.
Van Putten, T., Sr Sanders, D. G. Lithium in treatment failures. Journal of Nervous and Mental Disease, 1975, 161, 255–264.
Vidal, G., & Vidal, B. Imipramine et obsessions. Encephale, 1963, 52, 167–180.
Visitini, F. Terapia degli stati depressivi con Tofranil. Giornale Psychiatrico Neuropatologico, 1959, 30, 3–8.
Waxman, D. A general practice investigation on the use of clomipramine in obsessional and phobic disorders. Journal of International Medical Research, 1973, 1, 417–420.
Waxman, D. An investigation into the use of anafranil in phobic and obsessional disorders. Scottish Medical Journal, 1975, 20, 61–66.
Weissman, M., & Bothwell, S. Assessment of social adjustment by patient self-report. Archives of General Psychiatry, 1976, 33, 111–115.
Woodruff, R., & Pitts, F. M. Monozygotic twins with obsessional illness. American Journal of Psychiatry, 1964, 120, 1075–1080.
Wyndowe, J., Solyom, L., & Ananth, J. Anafranil in obsessive compulsive neurosis. Current Therapeutic Research, 1975, 18, 611–617.
Yaryura-Tobias, J. A., & Bhagawan, H. N. L-tryptophan in obsessivecompulsive disorders. American Journal of Psychiatry, 1977, 134, 1298–1299.
Yaryura-Tobias, J. A., Neziroglu, F., & Bergman, L. Clomipramine for obsessive compulsive neurosis: An organic approach. Current Therapeutic Research, 1976, 20, 541–547.
Youdim, M. B. H. Multiple forms of mitrochondrial monoamine oxidase. British Medical Bulletin, 1973, 29, 120–122.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Springer Science+Business Media New York
About this chapter
Cite this chapter
Ananth, J. (1985). Pharmacotherapy of Obsessive-Compulsive Disorder. In: Mavissakalian, M., Turner, S.M., Michelson, L. (eds) Obsessive-Compulsive Disorder. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0542-0_5
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0542-0_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0544-4
Online ISBN: 978-1-4899-0542-0
eBook Packages: Springer Book Archive